Companies Dominating the Enoxaparin API Market
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sanofi S.A.
- Aspen Pharmacare Holdings Limited
- Leo Pharma A/S
- Intas Pharmaceuticals Ltd.
- Alchem International Ltd.
- Opocrin S.p.A.
- Hikma Pharmaceuticals PLC
- Sandoz International GmbH
- Dr. Reddy's Laboratories Ltd.
Browse Key Market Insights with Data Illustration:
In the News
- Sanofi acquired Synthorx, Inc., a US-based gene therapy company focused on developing RNA interference (RNAi) therapeutics for rare genetic diseases, for USD 8.9 billion. This acquisition expanded Sanofi's gene therapy pipeline and strengthened its presence in the rare disease market.
- Sanofi acquired Translate Bio, Inc., a US-based mRNA therapeutics company, for USD 3.2 billion. This acquisition will further leverage Sanofi's expertise in mRNA technology and strengthen its pipeline in various therapeutic areas.
